CMS Behind In Medicare Pricing Audits That Help Federal Government Prevent Pricing Fraud, GAO Report Finds
CMS has not completed the majority of its scheduled audits of 2006 drug pricing information, which could hinder the government in recognizing and preventing pricing fraud in the Medicare prescription drug benefit, according to a Government Accountability Office report released on Friday, CongressDaily reports.